标题
Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 9, Issue 1, Pages 69-79
出版商
Informa UK Limited
发表日期
2015-11-05
DOI
10.1586/17512433.2016.1102052
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Thyroid Carcinoma, Version 2.2014
- (2017) R. Michael Tuttle et al. Journal of the National Comprehensive Cancer Network
- Osteonecrosis of the jaw in a patient receiving cabozantinib
- (2015) R Marino et al. AUSTRALIAN DENTAL JOURNAL
- Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis
- (2015) V. R. Belum et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Population Pharmacokinetic Model of Cabozantinib in Patients with Medullary Thyroid Carcinoma and Its Application to an Exposure-Response Analysis
- (2015) Dale Miles et al. CLINICAL PHARMACOKINETICS
- Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit
- (2015) Rashmi R. Shah et al. DRUG SAFETY
- THERAPY OF ENDOCRINE DISEASE: Response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis
- (2015) E. N. Klein Hesselink et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Sorafenib for the treatment of thyroid cancer: an updated review
- (2015) Jolanta Krajewska et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK
- (2015) Linh Nguyen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials
- (2014) Wei-Xiang Qi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms
- (2014) Sariah Liu et al. CANCER TREATMENT REVIEWS
- Cabozantinib: A Review of Its Use in Patients with Medullary Thyroid Cancer
- (2014) Sheridan M. Hoy DRUGS
- ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid effects of tyrosine kinase inhibitors
- (2014) Frédéric Illouz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network
- (2014) Marie-Hélène Massicotte et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H
- (2014) Keith C. Bible et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
- (2014) Ze-Feng Zhang et al. PLoS One
- Cabozantinib-Induced Thyroid Dysfunction: A Review of Two Ongoing Trials for Metastatic Bladder Cancer and Sarcoma
- (2014) Sahzene Yavuz et al. THYROID
- Overview and Management of Dermatologic Events Associated with Targeted Therapies for Medullary Thyroid Cancer
- (2014) Mario E. Lacouture et al. THYROID
- 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension
- (2013) Giuseppe Mancia et al. BLOOD PRESSURE
- Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma
- (2013) E. Fox et al. CLINICAL CANCER RESEARCH
- Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma
- (2013) Cristina Rodríguez-Antona et al. ENDOCRINE-RELATED CANCER
- Toxic cardiomyopathy leading to fatal acute cardiac failure related to vandetanib: a case report with histopathological analysis
- (2013) Rafael Selbach Scheffel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Tyrosine Kinase Inhibitor–Induced Thyroid Disorders: A Review and Hypothesis
- (2013) Noriko Makita et al. THYROID
- In Vitro and In Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer
- (2013) Frauke Bentzien et al. THYROID
- Aerodigestive Fistula Formation as a Rare Side Effect of Antiangiogenic Tyrosine Kinase Inhibitor Therapy for Thyroid Cancer
- (2013) Dean P. Blevins et al. THYROID
- Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma
- (2013) Serena Giunti et al. International Journal of Endocrinology
- Mechanisms of TKI-induced diarrhea in cancer patients
- (2013) Joanne M. Bowen Current Opinion in Supportive and Palliative Care
- Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study
- (2012) Sandra Feldt et al. EUROPEAN JOURNAL OF CANCER
- Risk of venous thromboembolic events associated with VEGFR-TKIs: A systematic review and meta-analysis
- (2012) Wei-Xiang Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Meta-Analysis of Randomized Controlled Trials for the Incidence and Risk of Treatment-Related Mortality in Patients With Cancer Treated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors
- (2012) Fabio A.B. Schutz et al. JOURNAL OF CLINICAL ONCOLOGY
- How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals
- (2012) Ka Kit Wong et al. NUCLEAR MEDICINE COMMUNICATIONS
- Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis
- (2012) Jiajie Zang et al. PLoS One
- Tyrosine Kinase Inhibitors Noncompetitively Inhibit MCT8-Mediated Iodothyronine Transport
- (2011) Doreen Braun et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib in Medullary Thyroid Carcinoma: Time to Focus the Spotlight on This Rare Disease
- (2011) Yariv Houvras et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- Fatal Heart Failure After a 26-Month Combination of Tyrosine Kinase Inhibitors in a Papillary Thyroid Cancer
- (2011) Marie-Elisabeth Toubert et al. THYROID
- Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
- (2010) L. L. Carr et al. CLINICAL CANCER RESEARCH
- Dual PET/CT with 18F-DOPA and 18F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging
- (2010) M.C. Marzola et al. EJSO
- Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Bruce G. Robinson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
- (2010) Elaine T. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Sunitinib in Advanced Medullary Thyroid Carcinoma: Intermediate Results of Phase II THYSU
- (2010) A. Ravaud et al. ONCOLOGIST
- Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas
- (2009) M M Moura et al. BRITISH JOURNAL OF CANCER
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
- (2009) Martin J. Schlumberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
- (2009) Richard T. Kloos (Chair) et al. THYROID
- Tyrosine kinase inhibitors and modifications of thyroid function tests: a review
- (2008) Frédéric Illouz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
- (2008) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas
- (2008) S. Dvorakova et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
- (2008) Steven I. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started